# NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE

> **NIH NIH N02** · IRISYS, INC. · 2022 · $639,151

## Abstract

NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE AND STUDY THE SHELF-LIFE.

## Key facts

- **NIH application ID:** 10710314
- **Project number:** 75N98019D00058-0-759102200003-1
- **Recipient organization:** IRISYS, INC.
- **Principal Investigator:** ROBERT GIANNINI
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $639,151
- **Award type:** —
- **Project period:** 2022-04-11 → 2026-04-10

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10710314

## Citation

> US National Institutes of Health, RePORTER application 10710314, NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE (75N98019D00058-0-759102200003-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10710314. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*